The influence of MR field strength on the detection of focal liver lesions with superparamagnetic iron oxide

European Radiology

Volumn 7, Issue 6, 1997, Pages 887-892

  Deckers, F ^a   Corthouts, B ^a   Nackaerts, Y ^a   Ozsarlak, O ^a   Parizel, P M ^a   De Schepper, A M ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Contrast media; Liver; Liver neoplasms; MR imaging; Superparamagnetic iron oxide particles

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; IRON; OXIDE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ENHANCEMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER DISEASE; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZATION;

ADULT; AGED; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; INFUSIONS, INTRAVENOUS; IRON; LIVER; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; PROSPECTIVE STUDIES; RANDOM ALLOCATION;

EID: 0030625166     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300050222     Document Type: Article

References (19)

1. Ferrucci JT, Stark DD (1990) Iron-oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. Am J Roentgenol 155: 943-950
2. Halavaara JT, Lamminen AE, Bondestam S, Standertskjold-Nordenstam C-G, Hamberg L (1994) Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging. J Comput Assist Tomogr 18: 897-904
3. Winter TC, Freeny PC, Nghiem HV, Mack LA, Patten RM, Thomas CR, Elliot S (1993) MR imaging with superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions. Am J Roentgenol 161: 1191-1198
4. Stark DD, Weissleder R, Elizondo GE, Hahn PF, Saini S, Todd LE, Wittenbrg J, Ferrucci JT (1988) Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 168: 297-301
5. Weissleder R, Hahn PF, Stark DD, Elizondo G, Saini S, Todd LE, Wittenberg J, Ferrucci JT (1988) Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging. Radiology 169: 399-403
6. Vogl TJ, Hammerstingl R, Schwarz W, Mack MG, Muller PK, Pegios W, Keck H, Eibl-Eibesfeldt A, Hoelzl J, Woessmer B, Bergman C, Felix R (1996) Superparamagnetic iron-oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198: 881-887
7. Marchal G, Van Hecke P, Demaerel P, Decrop E, Kennis C, Baert AL, Scheuren E van der (1989) Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. Am J Roentgenol 152: 771-775
8. Thickmann D, Hendrick RE, Jerjan KA, Schanker CS (1990) Liver-lesion tissue contrast on MR images: effect of iron oxide concentration and magnetic field strength. Radiology 176: 557-562
9. Kreft B, Layer G, Steudel A, Spiller L, Heuck A, Muller A, Gieseke J, Reiser MF (1994) Evaluation of turbo spin echo sequences for MRI of focal liver lesions at 0.5 T. Eur Radiol 4: 106-113
10. Parizel PM, Van Riet B, Hasselt BAAM van, Van Goethem JW, Hauwe L van den, Dijkstra HAJ, Wiechen PJ van, de Schepper AM (1995) Influence of magnetic field strength on T2* decay and phase effects in gradient echo MRI of vertebral bone marrow. J Comput Assist Tomogr 19: 465-471
11. Schwartz LH, Seltzer SE, Adams DF, Tempany CMC, Piwnica-Worms DR, Silverman SG, Herman L, Herman LT, Hooshm-and R (1994) Effects of superparamagnetic iron oxide on liver and spleen using spin-echo and fast spin-echo magnetic resonance pulse sequences. Invest Radiol 29: S21-S23
12. Fretz CJ, Elizondo GE, Weissleder R, Hahn PF, Stark DD, Ferucci JT (1989) Superparamagnetic iron-oxide-enhanced MR imaging: pulse sequence optimization for detection of liver cancer. Radiology 172: 393-397
13. Grangier G, Tourniaire G, Mentha G, Schiau R, Howarth N, Chachuat A, Grossholz M, Terrier F (1994) Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. J Comput Assist Tomogr 18: 888-896
14. Hahn PF, Stark DD, Weissleder R, Elizondo G, Saini S, Ferrucci JT (1990) Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiology 174: 361-366
15. Clement O, Frija G, Chambon C, Schouman-Clayes E, Mosnier JF, Poupon MF, Baikau B (1991) Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging. Radiology 180: 31-36
16. Parizel PM, Dijkstra HAJ, Geenen GPJ, Kint PAM, Versteylen RJ, Wiechen PJ van, de Schepper AM (1995) Low- versus high-field MR imaging of the knee: a comparison of signal behavior and diagnostic performance. Eur J Radiol 19: 132-138
17. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton. CC, White DL, Jacobs P, Lewis J (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. Am J Roentgenol 152: 167-173
18. Majumdar S, Zoghbi S, Pope CF, Gore JC (1988) Quantitation of MR relaxation effects of iron oxide particles in liver and. spleen. Radiology 169: 653-655
19. Parizel PM, de Schepper AM (1996) Low field systems add to MRI's cost-effectiveness. Diagn Imaging Europe 12: 19-29